Chimeron Bio

Private

Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.chimeron.com/

Last Round

VC Round

Mar 2, 2025

Total Funding Raised

$1.68M

Company Overview

Chimeron Bio is a biotechnology company that develops self-amplifying RNA (saRNA) therapeutics and vaccines intended to treat diseases including cancer, infectious diseases, and genetic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

self-amplifying RNAsaRNAin-vivo CAR-TRNA therapeuticscancer vaccineimmuno-oncologyoff-the-shelf CAR-TmRNA 2.0gene deliverylarge payload deliverynanoparticle deliverypreclinical biotechnologyinfectious disease vaccinerare genetic disorders

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Chimeron Bio Comps

Public and private peers based on sector, stage, and business model.

Chimeron Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Chimeron Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Mar 2, 2025
Grant	Feb 21, 2024
Grant	Jun 6, 2023
Seed	Feb 28, 2022
Grant	Aug 28, 2020
Accelerator	Jun 1, 2017

View all Funding Rounds

Key People

Founding team and executive leadership

Kevin Heyeck

CEO and Director

Executive Team

Chimeron Bio Investors

Notable investors and investment history

Chimeron Bio investors
Investor	Rounds
National Cancer Institute	Grant
Dreavent Capital	Seed
Alexandria Venture Investments	Accelerator

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 2, 2025
Monthly visitors increased 57% MoM.
Mar 2, 2025
$14M raised in a VC Round.

View all signals

Chimeron Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Chimeron Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Chimeron Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania

Employee Range13

Year Founded2015

Last FundingMar 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.